POTENTIAL OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG DERIVATIVES FOR BLOOD GLUCOSE REGULATION IN TYPE 2 DIABETES MELLITUS. DJMP 2026, 2 (1), 26-37.